Financials
- Market Capitalization 22.95 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
13.29
Rapporto prezzo/fatturato
3.54
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 520 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 55.67 USD | -1.38% | -3.75% | +2.56% | +49.41% | 24.75 B USD | ||
| 532 | INSM Insmed Incorporated - Common Stock | 110.11 USD | +0.89% | -1.63% | +12.93% | -32.05% | 23.87 B USD | ||
| 565 | UTHR United Therapeutics Corporation - Common Stock | 526.66 USD | -1.66% | -6.20% | -4.84% | +78.38% | 22.35 B USD | ||
| 571 | BNTX BioNTech SE - American Depositary Shares | 90.40 USD | +0.37% | -3.10% | -0.36% | -17.89% | 21.69 B USD |